Skip to Main Content

Depression Screening and Follow-Up Series

Screen Early. Follow Up. Improve Outcomes.

The Depression Screening and Follow-Up Series is designed to support providers and practitioner staff in addressing one of the most common—and often under-identified—behavioral health conditions impacting patient populations. Depression is associated with increased healthcare utilization, chronic disease, substance use, and poor health outcomes, making early identification and effective management critical components of care.

Centered on the NCQA HEDIS measure DSF-E: Depression Screening and Follow-Up for Adolescents and Adults, this series provides practical, actionable guidance to help practices improve screening processes, ensure appropriate follow-up care, and strengthen care coordination. Topics include the use of standardized screening tools, interpretation of results, risk identification, and integration of behavioral health into whole-person care.

By incorporating these strategies into routine workflows, providers can improve screening performance, close gaps in care, and enhance patient engagement—ultimately supporting better health outcomes across populations.

Overview of Depression and Clinical Impact

Depression is one of the most common—and often under-identified—behavioral health conditions affecting patients across all age groups. Many individuals present with nonspecific symptoms, which can result in depression going unrecognized without formal screening.

Untreated depression is associated with increased healthcare utilization, higher costs, and poorer overall health outcomes. It is also strongly linked to chronic disease, substance use, and reduced adherence to treatment plans. Early identification and intervention are critical to improving both behavioral and physical health outcomes.

Introduction to the DSF-E HEDIS Measure

The NCQA HEDIS measure Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) evaluates the percentage of individuals age 12 and older who are:

  • Screened for clinical depression using a standardized, validated instrument, and
  • If screening is positive, receive appropriate follow-up care

The measure includes two key performance rates:

  • Depression Screening: Percentage of patients
    screened using a standardized tool
  • Follow-Up on Positive Screen: Percentage of patients who
    receive follow-up care within 30 days of a positive result 

This measure emphasizes both identifying depression and ensuring appropriate action is taken.

Why Does Routine Screening & Follow-up Matter?

  • Drives early identification of depression
  • Many patients—especially within Medicaid populations—do not actively report depressive symptoms
  • Screening creates a consistent, system-level safety net that can identify depression before it escalates
  • Closes behavioral health gaps in integrated care models
  • Promotes behavioral health as part of whole-person care
  • Ensures action—not just identification
  • Screening without follow-up has limited clinical value
  • This measure emphasizes closing the loop through treatment, referral, or reassessment

Improves overall health outcomes

  • Early identification leads to better outcomes
  • Coordinated care supports:
    • Improved adherence to medical
      treatment plans
    • Greater engagement with the care
      team
    • Fewer missed appointments

Why This Matters for Your Practice

  • Many complex members have undiagnosed or unmanaged depression
  • Improving performance on this measure can reduce:
    • Emergency department (ED) utilization
    • Inpatient stays
    • Care fragmentation